© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 9, 743-749,
May 3, 2000
© 2000 Oxford University Press
REPORTS |
Biologic Characteristics of Interval and Screen-Detected Breast Cancers
Affiliations of authors: F. D. Gilliland, Department of Preventive Medicine and the Norris Comprehensive Cancer Center, University of Southern California, Keck School of Medicine, Los Angeles, and New Mexico Tumor Registry, University of New Mexico Health Sciences Center, Albuquerque; N. Joste, G. Redlich (Department of Pathology), P. M. Stauber, W. C. Hunt (New Mexico Tumor Registry), R. Rosenberg (Department of Radiology), C. R. Key (New Mexico Tumor Registry and Department of Pathology), University of New Mexico Health Sciences Center.
Correspondence to: Frank D. Gilliland, M.D., Ph.D., 1540 Alcazar St. CHP 236, Los Angeles, CA 90033 (e-mail: gillilan{at}usc.edu).
Background: Interval breast cancer is defined as a cancer that is detected within 12 months after a negative mammogram. The failure of mammography to detect breast cancer depends on testing procedures, radiologist interpretation, patient characteristics, and tumor properties. Although errors by radiologists explain some interval cancers, another explanation is that the tumor is rapidly growing and was too small to be detected on the last mammogram. To determine whether markers of tumor growth rate are associated with risk of an interval cancer, we conducted a population-based study with the use of data collected statewide by the New Mexico Mammography Project. Methods: Among women who received a mammographic examination from 1991 throughout 1993, we ascertained records of all patients with breast cancer diagnosed within 12 months of a negative screening mammographic examination (interval cancers) and corresponding tumor samples, when available. We selected an age- and ethnicity-matched comparison group of control patients with screen-detected breast cancers diagnosed during the same period. In tumor samples, p53, bcl-2, and Ki-67 were examined immunologically and the apoptotic index was assessed histologically. We used logistic regression to determine whether interval cancers were associated with selected demographic, radiologic, and biologic characteristics. Results: It is more likely that mammography did not detect tumors with a high proportion of proliferating cells (>20%) than tumors with a low proportion of proliferating cells (<5%) (odds ratio [OR] = 4.09; 95% confidence interval [CI] = 1.14–14.65). The OR for mammographic failure was 2.96 (95% CI = 1.07–8.20) among cancers that expressed p53 compared with cancers that did not. Interval cancers also had fewer apoptotic cells. Approximately 75% of interval cancers appear to have tumors with 5% proliferating cells or more. Younger women had a higher proportion of rapidly proliferating and aggressive cancers. Conclusion: Rapidly growing and aggressive tumors account for a substantial proportion of mammographic failure to detect breast cancer, especially among younger women, who have a high proportion of aggressive cancers.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. Dong, D. A. Berry, T. B. Bevers, S.-W. Kau, L. Hsu, R. L. Theriault, and Y. Shen Prognostic Role of Detection Method and Its Relationship with Tumor Biomarkers in Breast Cancer: The University of Texas M. D. Anderson Cancer Center Experience Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1096 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. F. Boyd, H. Guo, L. J. Martin, L. Sun, J. Stone, E. Fishell, R. A. Jong, G. Hislop, A. Chiarelli, S. Minkin, et al. Mammographic Density and the Risk and Detection of Breast Cancer N. Engl. J. Med., January 18, 2007; 356(3): 227 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Carney, E. Steiner, M. E. Goodrich, A. J. Dietrich, C. J. Kasales, J. E. Weiss, and T. MacKenzie Discovery of Breast Cancers Within 1 Year of a Normal Screening Mammogram: How Are They Found? Ann. Fam. Med, November 1, 2006; 4(6): 512 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Chiarelli, V. A. Kirsh, N. S. Klar, R. Shumak, R. Jong, E. Fishell, M. J. Yaffe, and N. F. Boyd Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1856 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. F. Anderson and R. Matsuno Breast cancer heterogeneity: a mixture of at least two main types? J Natl Cancer Inst, July 19, 2006; 98(14): 948 - 951. [Full Text] [PDF]
|
|
|
|
 |
|
 F. Kamangar, G. M. Dores, and W. F. Anderson Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World J. Clin. Oncol., May 10, 2006; 24(14): 2137 - 2150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Collett, G. E. Eide, J. Arnes, I. M. Stefansson, J. Eide, A. Braaten, T. Aas, A. P. Otte, and L. A. Akslen Expression of Enhancer of Zeste Homologue 2 Is Significantly Associated with Increased Tumor Cell Proliferation and Is a Marker of Aggressive Breast Cancer Clin. Cancer Res., February 15, 2006; 12(4): 1168 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shen, Y. Yang, L. Y. T. Inoue, M. F. Munsell, A. B. Miller, and D. A. Berry Role of Detection Method in Predicting Breast Cancer Survival: Analysis of Randomized Screening Trials J Natl Cancer Inst, August 17, 2005; 97(16): 1195 - 1203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Kavanagh, J. Cawson, G. B. Byrnes, G. G. Giles, G. Marr, B. Tong, D. M. Gertig, and J. L. Hopper Hormone Replacement Therapy, Percent Mammographic Density, and Sensitivity of Mammography Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1060 - 1064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Collett, I. M. Stefansson, J. Eide, A. Braaten, H. Wang, G. E. Eide, S. O. Thoresen, W. D. Foulkes, and L. A. Akslen A Basal Epithelial Phenotype Is More Frequent in Interval Breast Cancers Compared with Screen Detected Tumors Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1108 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Elmore, K. Armstrong, C. D. Lehman, and S. W. Fletcher Screening for Breast Cancer JAMA, March 9, 2005; 293(10): 1245 - 1256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. M. Buist, P. L. Porter, C. Lehman, S. H. Taplin, and E. White Factors Contributing to Mammography Failure in Women Aged 40-49 Years J Natl Cancer Inst, October 6, 2004; 96(19): 1432 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Joensuu, T. Lehtimaki, K. Holli, L. Elomaa, T. Turpeenniemi-Hujanen, V. Kataja, A. Anttila, M. Lundin, J. Isola, and J. Lundin Risk for Distant Recurrence of Breast Cancer Detected by Mammography Screening or Other Methods JAMA, September 1, 2004; 292(9): 1064 - 1073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Crystal, S. D. Strano, S. Shcharynski, and M. J. Koretz Using Sonography to Screen Women with Mammographically Dense Breasts Am. J. Roentgenol., July 1, 2003; 181(1): 177 - 182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Kolb, J. Lichy, and J. H. Newhouse Comparison of the Performance of Screening Mammography, Physical Examination, and Breast US and Evaluation of Factors that Influence Them: An Analysis of 27,825 Patient Evaluations Radiology, October 1, 2002; 225(1): 165 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Narod and M.-P. Dube Re: Biologic Characteristics of Interval and Screen-Detected Breast Cancers J Natl Cancer Inst, January 17, 2001; 93(2): 151 - 151. [Full Text] [PDF]
|
|
|
|
|
|
K.-A. Phillips RESPONSE: Re: Biologic Characteristics of Interval and Screen Detected Breast Cancers J Natl Cancer Inst, January 17, 2001; 93(2): 151a - 152a. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kerlikowske, P. A. Carney, B. Geller, M. T. Mandelson, S. H. Taplin, K. Malvin, V. Ernster, N. Urban, G. Cutter, R. Rosenberg, et al. Performance of Screening Mammography among Women with and without a First-Degree Relative with Breast Cancer Ann Intern Med, December 5, 2000; 133(11): 855 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Eisinger, C. Juliain-Reynier, and H. Sobol Re: Biologic Characteristics of Interval and Screen-Detected Breast Cancers J Natl Cancer Inst, September 20, 2000; 92(18): 1533 - 1534. [Full Text] [PDF]
|
|